FDA OKs First Oral Agent for Eosinophilic Esophagitis ...Middle East

Medscape - News
Budesonide oral suspension is indicated for 12 weeks of treatment of EoE in adults and children as young as 11 years. Medscape Medical News

Hence then, the article about fda oks first oral agent for eosinophilic esophagitis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs First Oral Agent for Eosinophilic Esophagitis )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News